Clinical trial

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With…

NCT00488267 · ZARS Pharma Inc., Industry · Completed

Key facts

NCT number NCT00488267
Title Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee
Official title A Randomized, Double-Blind, 12-Week Study to Evaluate the Efficacy of ThermoProfen™ in the Treatment of Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee (ZMK-301)
Lead sponsor ZARS Pharma Inc., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Osteoarthritis
Intervention type Drug
Interventions ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System), Placebo Matrix/CHADD Patch, Ketoprofen matrix/placebo CHADD Patch
Enrollment 679
Start date Jun 1, 2007
Primary completion Jun 1, 2008
Completion Sep 1, 2008
First posted Jun 20, 2007
Last update posted May 30, 2012
Countries United States

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies